AchievementsWhat sets Bristol-Myers Squibb apart? It's our commitment to patients with serious diseases, and our focus on finding innovative medicines to combat those diseases.
Over the years, Bristol-Myers Squibb and its employees have received numerous distinguished awards and recognitions, including the National Medal of Technology, the Lasker Award for Medical Research and the Prix Galien Award. Also, we've been hailed year after year as one of the best companies for working mothers, a great place to work for scientists and an acknowledged industry leader in environment, health and safety.
Below is a selection of awards and recognitions we have received.
Bristol-Myers Squibb’s Opdivo was a unanimous selection for Pharmaceutical Executive Magazine/PharmExec.com’s 2016 Brand of the Year. Pharm Exec’s Editorial Advisory Board notes that Opdivo has “raced into the lead position in the treatment-shifting immuno-oncology space behind launches in three key cancers—melanoma, lung, and renal,” in announcing the 10th annual award in its May issue.
Bristol-Myers Squibb was honored as a Top 30 Best-of-the-Best company by the National Gay & Lesbian Chamber of Commerce in collaboration with its partners in the National Business Inclusion Consortium. This year’s inaugural list recognizes U.S. companies committed to diversity and inclusion across all community sectors.
For the eighth consecutive year, Bristol-Myers Squibb ranks among the top 10 on Corporate Responsibility magazine’s list of the 100 Best Corporate Citizens. The company ranked sixth this year and has achieved the number one ranking three times – in 2009, 2012 and 2014.
Bristol-Myers Squibb is featured as one of the Top 8 Pharma Companies to Work For in a survey conducted by Biospace, a leading online community for industry news and careers. “People join Bristol-Myers Squibb because they are passionate about working for patients,” said Ann Judge, Global Head of Human Resources, Bristol-Myers Squibb. “We empower our people to pursue innovation and challenge the status quo. Our diverse global team is reflective of an inclusive culture that appreciates differences and embraces new ideas.”
Bristol-Myers Squibb is recognized as a 2016 Energy Star Partner of the Year by the U.S. Environmental Protection Agency and U.S. Department of Energy. We are engaged in comprehensive policies and programs to manage energy use at facilities worldwide. Bristol-Myers Squibb is committed to the environment—implementing 50 new energy projects in 2015 alone.
Bristol-Myers Squibb has been named one of the 2016 NAFE Top Companies for Executive Women. The company was recognized for leadership initiatives, executive mentoring and sponsorship programs for female employees. Additional education and training through our seven People and Business Resource Groups, five on-site child care centers and a new network for people who choose adoption were also highlighted. Bristol-Myers Squibb remains dedicated to engaging, promoting and retaining our talented employees.
Bristol-Myers Squibb is recognized by Forbes as one of America’s Best Employers for 2016. Our employees are committed to our mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Bristol-Myers Squibb was honored with the “Simply the Best” Award from the Bonnie J. Addario Lung Cancer Foundation (ALCF) for improving and advancing research for lung cancer. The award was part of ALCF’s Tenth Annual “Simply the Best“ Gala, which recognizes researchers, dedicated physicians and clinicians for their ongoing work fighting lung cancer.
Bristol-Myers Squibb ranks number four among the World’s Most Admired Companies in the pharmaceutical industry, according to the 2016 annual ranking published by FORTUNE magazine. Bristol-Myers Squibb ranked in the top three pharmaceutical companies for innovation, people management, quality of products and services, and use of corporate assets.
Bristol-Myers Squibb is recognized by Fast Company -- the trend-setting business innovations magazine and social platform -- as one of the World’s Most Innovative Companies for 2016 and one of the Top 10 Most Innovative Companies in Biotech.
Bristol-Myers Squibb received the 2015 Collaborator Award from the Multiple Myeloma Research Foundation (MMRF) in recognition of the company’s commitment to collaboration and to advancing the research and development of novel therapies for patients with multiple myeloma. The Collaborator Award is part of an annual initiative by the MMRF to recognize the exceptional work of its partners from industry and academia who have played a critical role toward pursuing innovative means in the development of next-generation multiple myeloma treatments. Watch the video.
Bristol-Myers Squibb has been honored with the 2015 Society for Immunotherapy of Cancer (SITC) Collaborator Award (Industry) for demonstrating ongoing collaboration and continued commitment toward the advancement of cancer immunotherapy. The award was part of SITC’s 30th Anniversary Awards, which were created to highlight groups and individuals who stand out as advocates for the society, and whose involvement in the organization has strengthened its position in the growing field of cancer immunotherapy.
In October, Bristol-Myers Squibb was recognized by Science Careers as a 2015 Top 20 R&D Employer. Our company was lauded for being an “Innovating leader in the industry” and commended for the respect afforded our employees and the loyalty they show in return. Science also noted our willingness to take risks that are backed by good science and our leading position in Immuno-Oncology. Overall, Science found that Bristol-Myers Squibb is an exciting place to work.
Bristol-Myers Squibb’s Opdivo received the Prix Galien USA 2015 Award for Best Biotechnology Product. This represents the second award from Prix Galien USA given to Bristol-Myers Squibb’s Immuno-Oncology portfolio. Yervoy was awarded the prestigious Prix Galien USA prize for Best Biotechnology Product in 2012.
Bristol-Myers Squibb is one of the 2015 Working Mother 100 Best Companies - marking the 18th consecutive year that our company has made the list. The company was recognized for family-friendly policies and culture.
Bristol-Myers Squibb is recognized as one of Dow Jones’ 2015 North America Index of Leading Sustainable Companies. Our efforts to promote economic, social and environmental sustainability are core to our company’s mission and reflect our ongoing commitment to patients, our employees and partners, the environment and communities around the world.
In June, the MIT Technology Review named Bristol-Myers Squibb to its 50 Smartest Companies list for 2015. Bristol-Myers Squibb was ranked No. 26 and recognized as a leader in Immuno-Oncology.
For the seventh consecutive year, Bristol-Myers Squibb ranks among the top 10 on Corporate Responsibility magazine’s list of the 100 Best Corporate Citizens. The company ranked sixth this year and has achieved the number one ranking three times - in 2009, 2012 and 2014.
Bristol-Myers Squibb was ranked number four among the World’s Most Admired Companies in the pharmaceutical industry, according to the 2015 annual ranking published by FORTUNE magazine. Bristol-Myers Squibb ranked in the top three pharmaceutical companies for innovation and social responsibility.
For the ninth consecutive year, Bristol-Myers Squibb received a perfect score of 100 percent on the 2015 Corporate Equality Index (CEI), a national review of workplace equality conducted annually by the Human Rights Campaign Foundation, the nation’s largest lesbian, gay, bisexual and transgender (LGBT) civil rights organization.